Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm - Université de Nantes Accéder directement au contenu
Article Dans Une Revue New England Journal of Medicine Année : 2019

Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm

Jean-Baptiste Lascarrou
Hamid Merdji
  • Fonction : Auteur
Amélie Le Gouge
Gwenhael Colin
  • Fonction : Auteur
Guillaume Grillet
  • Fonction : Auteur
Patrick Girardie
  • Fonction : Auteur
Elisabeth Coupez
  • Fonction : Auteur
Pierre-François Dequin
Alain Cariou
  • Fonction : Auteur
Thierry Boulain
Noelle Brule
  • Fonction : Auteur
Jean-Pierre Frat
Pierre Asfar
Nicolas Pichon
  • Fonction : Auteur
Mickael Landais
Gaëtan Plantefeve
  • Fonction : Auteur
Jean-Pierre Quenot
Jean-Charles Chakarian
  • Fonction : Auteur
Michel Sirodot
  • Fonction : Auteur
Stéphane Legriel
Julien Letheulle
  • Fonction : Auteur
Didier Thevenin
  • Fonction : Auteur
Arnaud Desachy
  • Fonction : Auteur
Arnaud Delahaye
  • Fonction : Auteur
Vlad Botoc
  • Fonction : Auteur
Sylvie Vimeux
  • Fonction : Auteur
Frederic Martino
  • Fonction : Auteur
Jean Reignier
  • Fonction : Auteur
Crics-Triggersep Group
  • Fonction : Auteur

Résumé

BACKGROUND: Moderate therapeutic hypothermia is currently recommended to improve neurologic outcomes in adults with persistent coma after resuscitated out-of-hospital cardiac arrest. However, the effectiveness of moderate therapeutic hypothermia in patients with nonshockable rhythms (asystole or pulseless electrical activity) is debated. METHODS: We performed an open-label, randomized, controlled trial comparing moderate therapeutic hypothermia (33° C during the first 24 hours) with targeted normothermia (37° C) in patients with coma who had been admitted to the intensive care unit (ICU) after resuscitation from cardiac arrest with nonshockable rhythm. The primary outcome was survival with a favorable neurologic outcome, assessed on day 90 after randomization with the use of the Cerebral Performance Category (CPC) scale (which ranges from 1 to 5, with higher scores indicating greater disability). We defined a favorable neurologic outcome as a CPC score of 1 or 2. Outcome assessment was blinded. Mortality and safety were also assessed. RESULTS: From January 2014 through January 2018, a total of 584 patients from 25 ICUs underwent randomization, and 581 were included in the analysis (3 patients withdrew consent). On day 90, a total of 29 of 284 patients (10.2%) in the hypothermia group were alive with a CPC score of 1 or 2, as compared with 17 of 297 (5.7%) in the normothermia group (difference, 4.5 percentage points; 95% confidence interval [CI], 0.1 to 8.9; P\,=\,0.04). Mortality at 90 days did not differ significantly between the hypothermia group and the normothermia group (81.3% and 83.2%, respectively; difference, -1.9 percentage points; 95% CI, -8.0 to 4.3). The incidence of prespecified adverse events did not differ significantly between groups. CONCLUSIONS: Among patients with coma who had been resuscitated from cardiac arrest with nonshockable rhythm, moderate therapeutic hypothermia at 33° C for 24 hours led to a higher percentage of patients who survived with a favorable neurologic outcome at day 90 than was observed with targeted normothermia. (Funded by the French Ministry of Health and others; HYPERION ClinicalTrials.gov number, NCT01994772.).

Dates et versions

hal-03158805 , version 1 (04-03-2021)

Identifiants

Citer

Jean-Baptiste Lascarrou, Hamid Merdji, Amélie Le Gouge, Gwenhael Colin, Guillaume Grillet, et al.. Targeted Temperature Management for Cardiac Arrest with Nonshockable Rhythm. New England Journal of Medicine, 2019, 381 (24), pp.2327-2337. ⟨10.1056/NEJMoa1906661⟩. ⟨hal-03158805⟩
30 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More